Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with Autism

Abstract

In the absence of standard pharmacological treatment for children with autistic disorder, a placebo-controlled study remains the most appropriate method of testing efficacy and safety. The clinical relevance of this study is enhanced by the addition of an extended maintenance phase followed by a placebo discontinuation.